Clinical Trials Logo

Clinical Trial Summary

The overall goal of the SMC is to help reduce posttraumatic stress symptomology for pregnant persons with a history of trauma.


Clinical Trial Description

The study is a pilot randomized waitlist-controlled trial that examines the preliminary efficacy of the SMC for reducing PTSD symptomology as compared to a waitlist control group. Also, it aims to assess the feasibility and acceptability of the SMC. It examines how changes in the theorized mechanisms (emotion regulation, interpersonal sensitivity) mediate the relationship between the intervention and PTSD symptomology. ;


Study Design


NCT number NCT06318663
Study type Interventional
Source State University of New York at Buffalo
Contact Mickey Sperlich, PhD
Phone (716)-645-9087
Email msperlic@buffalo.edu
Status Recruiting
Phase N/A
Start date December 12, 2023
Completion date December 12, 2024